These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19715563)

  • 1. Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany.
    Eidt-Koch D; Mittendorf T; Greiner W
    BMC Pediatr; 2009 Aug; 9():55. PubMed ID: 19715563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement Properties of the Online EuroQol-5D-Youth Instrument in Children and Adolescents With Type 1 Diabetes Mellitus: Questionnaire Study.
    Mayoral K; Rajmil L; Murillo M; Garin O; Pont A; Alonso J; Bel J; Perez J; Corripio R; Carreras G; Herrero J; Mengibar JM; Rodriguez-Arjona D; Ravens-Sieberer U; Raat H; Serra-Sutton V; Ferrer M
    J Med Internet Res; 2019 Nov; 21(11):e14947. PubMed ID: 31714252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
    Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
    Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of the German version of EQ-5D-Y-5L to measure health-related quality of life in children and adolescents: Identification of response labels and pilot testing].
    Kreimeier S; Greiner W
    Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():24-34. PubMed ID: 31378708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis.
    Mukuria C; Rowen D; Acaster S; McGarry LJ; Lou Y; Sosnay PR; Quittner AL
    J Patient Rep Outcomes; 2024 Feb; 8(1):24. PubMed ID: 38416239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of the health-related quality of life instrument EQ-5D-Y-5L among patients in child and adolescent psychiatric inpatient care.
    Krig S; Åström M; Kulane A; Burström K
    Acta Paediatr; 2021 Mar; 110(3):899-906. PubMed ID: 32815186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis.
    Quittner AL; Buu A; Messer MA; Modi AC; Watrous M
    Chest; 2005 Oct; 128(4):2347-54. PubMed ID: 16236893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study.
    Wilke S; Janssen DJ; Wouters EF; Schols JM; Franssen FM; Spruit MA
    Health Qual Life Outcomes; 2012 Aug; 10():98. PubMed ID: 22909154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring health-related quality of life with the EQ-5D-Y instrument in children and adolescents with asthma.
    Bergfors S; Åström M; Burström K; Egmar AC
    Acta Paediatr; 2015 Feb; 104(2):167-73. PubMed ID: 25393977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western Cape, South Africa: psychometric properties, feasibility and usefulness - a longitudinal, analytical study.
    Scott D; Ferguson GD; Jelsma J
    Health Qual Life Outcomes; 2017 Jan; 15(1):12. PubMed ID: 28103872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the web-based Spanish and Catalan versions of the Euroqol 5D-Y (EQ-5D-Y) and comparison of results with the paper version.
    Robles N; Rajmil L; Rodriguez-Arjona D; Azuara M; Codina F; Raat H; Ravens-Sieberer U; Herdman M
    Health Qual Life Outcomes; 2015 Jun; 13():72. PubMed ID: 26037720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population health status based on the EQ-5D-Y-3L among adolescents in Sweden: Results by sociodemographic factors and self-reported comorbidity.
    Åström M; Persson C; Lindén-Boström M; Rolfson O; Burström K
    Qual Life Res; 2018 Nov; 27(11):2859-2871. PubMed ID: 30196340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indonesia youth population norms for EQ-5D-Y-3 L, EQ-5D-Y-5 L and the PedsQL generic core scale: lower health related quality of life relates to high economic status and stress.
    Fitriana TS; Purba FD; Stolk E; Busschbach JJV
    BMC Public Health; 2023 Jun; 23(1):1124. PubMed ID: 37308934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the EQ-5D measure quality of life in schizophrenia?
    Halling Hastrup L; Nordentoft M; Hjorthøj C; Gyrd-Hansen D
    J Ment Health Policy Econ; 2011 Dec; 14(4):187-96. PubMed ID: 22345360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement properties of the EQ-5D-Y administered through a smartphone app in children with asthma: a longitudinal questionnaire study.
    Mayoral K; Garin O; Lizano-Barrantes C; Pont A; Caballero-Rabasco AM; Praena-Crespo M; Valdesoiro-Navarrete L; Guerra MT; Castillo JA; Mir I; Tato E; Alonso J; Serra-Sutton V; Pardo Y; Ferrer M;
    Health Qual Life Outcomes; 2022 Mar; 20(1):51. PubMed ID: 35346225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents.
    Åström M; Rolfson O; Burström K
    Appl Health Econ Health Policy; 2022 May; 20(3):383-393. PubMed ID: 35083734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-cultural adaptation and content validation of the Singapore English version of EQ-5D-Y: a qualitative study.
    Lee-Yin Tan R; Ng ZM; Chen LA; Herdman M; Luo N
    Health Qual Life Outcomes; 2024 Sep; 22(1):82. PubMed ID: 39334361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD.
    Bouwmans C; van der Kolk A; Oppe M; Schawo S; Stolk E; van Agthoven M; Buitelaar J; van Roijen L
    Eur J Health Econ; 2014 Dec; 15(9):967-77. PubMed ID: 24233919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "The validity of the EQ-5D-5L in measuring quality of life benefits of breast reconstruction".
    Kouwenberg CAE; Kranenburg LW; Visser MS; Busschbach JJ; Mureau MAM
    J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):52-61. PubMed ID: 30270015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.